ClinicalTrials.Veeva

Menu
C

Clinilabs Drug Development Corporation | Eatontown, NJ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

INZ-701

Parent organization

This site is a part of Clinilabs Drug Development Corporation

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

An Open Label Extension Study of CTI-1601 in Subjects With Friedreich's Ataxia (Jive)

This is an open-label extension (OLE) study designed to evaluate the long-term safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), an...

Invitation-only
Friedreich Ataxia
Biological: CTI-1601

The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of multiple ascending doses of INZ-...

Active, not recruiting
Autosomal Recessive Hypophosphatemic Rickets
Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
Drug: INZ-701

Trial sponsors

I
L

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems